Brief: Adagene Inc - Partners With Conjugatebio For Antibody Drug Conjugate Development
08/07/2025 12:25
July 8 (Reuters) - Adagene Inc 978y.F: ADAGENE INC - PARTNERS WITH CONJUGATEBIO FOR ANTIBODY DRUG CONJUGATE DEVELOPMENT ADAGENE INC - TO RECEIVE UNDISCLOSED UPFRONT AND ROYALTY PAYMENTS ADAGENE INC - RETAINS NON-ADC RIGHTS TO PARTNERED ANTIBODY Source text: ID:nGNX5j5hy9 Further company coverage: [978y.F] ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adagene
See all newsBrief: Adagene Inc Announces Offering Of American Depositary Shares
Brief: Adagene Announces FDA Fast Track Designation For Muzastotug (Adg126)
Brief: Adagene Expands SAFEBody Deal With Exelixis To Develop Third Novel Masked Antibody-Drug Conjugate
Brief: Adagene Inc - Partners With Conjugatebio For Antibody Drug Conjugate Development
Brief: Adagene Announces Up To $25 Million Strategic Investment From Sanofi